CVS Health Corporation (NYSE:CVS) Receives $94.82 Consensus PT from Analysts

CVS Health Corporation (NYSE:CVS) has earned a consensus rating of “Moderate Buy” from the twenty-three ratings firms that are currently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $94.8182.

A number of equities research analysts recently commented on the stock. Raymond James Financial raised their price objective on shares of CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Bank of America cut their price target on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. Morgan Stanley increased their price objective on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Finally, Barclays lifted their price objective on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th.

Institutional Trading of CVS Health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Cantor Fitzgerald Investment Advisors L.P. grew its holdings in CVS Health by 1.6% in the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after buying an additional 6,615 shares in the last quarter. National Pension Service grew its stake in shares of CVS Health by 3.1% in the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after acquiring an additional 119,189 shares in the last quarter. Alpha Omega Wealth Management LLC grew its stake in shares of CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares in the last quarter. AE Wealth Management LLC raised its stake in CVS Health by 6.2% in the 3rd quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after purchasing an additional 14,983 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in CVS Health by 186.6% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock valued at $30,568,000 after purchasing an additional 258,050 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS opened at $74.51 on Thursday. The stock has a 50 day simple moving average of $78.90 and a 200 day simple moving average of $75.16. CVS Health has a 52-week low of $53.36 and a 52-week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm has a market capitalization of $94.59 billion, a PE ratio of 196.09, a P/E/G ratio of 0.68 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period last year, the company posted $1.09 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. Sell-side analysts predict that CVS Health will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.6%. CVS Health’s payout ratio is 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.